Lindbrook Capital, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q2 2023$312670.00%
Q4 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2020$22,0001,0000.01%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$34,466,00016.86%
Samsara BioCapital, LLC 1,675,579$31,652,0004.97%
First Light Asset Management, LLC 2,191,439$41,396,0002.73%
FRAZIER MANAGEMENT LLC 1,468,663$27,743,0002.22%
AJU IB Investment Co., Ltd. 175,000$3,306,0002.13%
Opaleye Management Inc. 537,800$10,159,0001.90%
Parkman Healthcare Partners LLC 163,389$3,086,0000.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,233,695$42,194,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$2,629,0000.63%
BVF INC/IL 826,825$15,619,0000.61%
View complete list of SUTRO BIOPHARMA INC shareholders